Global labeling and packaging are central to clinical supply performance, shaping regulatory compliance, serialization, and design choices that affect patient safety now.
- Clinical Supply Chains For Decentralized Trials In Sub-Saharan Africa
- What Clinical Trial Supply Teams Actually Need From CQV Before Batch Release
- Clinical Trial Supply Failures Start Before First Patient In
- Clinical Trial Supply Impact Of ICSR Processing Delays
- Achieving Forecasting And Inventory Agility In Modern Clinical Supply Chains
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement
- How The Iran Conflict Threatens Global Clinical Supply Chains
- Optimizing CMO/CRO Partnerships To Improve Clinical Trial Supply Performance
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Unblinding Risks In RTSM: What's Still Going Wrong, And How Korio Fixes It
Protecting study integrity requires more than just luck. Learn how systemic gaps lead to unintentional unblinding and how a proactive, engine-based approach can safeguard your clinical data.
-
A Custom IRT System Facilitates Precision Medicine Studies
As the industry continues to embrace personalized medicine, the ability to implement and support an atypical supply chain is crucial.
-
Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization
While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.
-
Automation Testing In RTSM Software: What Is It And What's The Impact
Move beyond the limitations of manual oversight to see how automated frameworks ensure precision, speed, and reliability for the most sophisticated and adaptive clinical trial designs.
-
Advantages Of Sourcing Biosimilars Vs. Branded Biologics In Clinical Trials
Evaluate biosimilar alternatives during clinical trial planning to reduce comparator drug costs and improve overall study efficiency without compromising trial integrity.
-
Using IRT Data To Automate And Optimize Clinical Supply
Learn how clinical teams can save between $150,000 and $1 million in annual drug and shipping costs through automated supply optimization.
-
From Bench To Breakthrough: How Custom Kitting Fuels Precision Trials
Reduce trial variability and ensure protocol compliance with standardized custom kitting that transforms complex sample collection into a streamlined, strategic advantage for clinical success.
-
Time, Logistics, And Manufacturing In Autologous Cell Therapy Clinical Trials
Learn how the establishment of effective guidelines and standardization relevant to cell therapy development can help to minimize delays and lead to more positive outcomes.
-
Writing Effective Clinical Regulatory Documents For Therapy Trials
Clinical medical writing for gene therapy regulatory documents is a demanding, detail-oriented task that diverges significantly from medical writing for more traditional therapies.
-
5 Tips To Put The Right Systems In Place For Successful Clinical Trials
Before you dive into clinical trials, ask yourself: Is my company operationally ready to handle the complexity? Learn about key upgrades that can help you streamline operations and reduce risk.
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 2 – Where Assumptions Break Trials
- What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement
- From Invisible to Integral: Inviting Clinical Supply Expertise to the Planning Table
- Invisible Yet Accountable: How Clinical Supply Pressures Build Strategic Leaders
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.